Browsing by Author "Argilés Martinez, Guillem"
Now showing items 1-11 of 11
-
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Dienstmann, Rodrigo; Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Ortiz Velez, Carolina; Macarulla Mercadé, Teresa; Capdevila Castillon, Jaume; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Ruiz Pace, Fiorella; Viaplana Donato, Cristina; Landolfi, Stefania; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep (Wiley, 2017-06-15) -
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S. J.; Tabernero Caturla, Josep; Molife, L. R.; Soria, J.-C.; Cervantes, A.; Vogelzang, N. J.; Argilés Martinez, Guillem (Elsevier, 2020-05) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Sardo, Emilia; Mulet Margalef, Núria; Salva Ballabrera, Francesc; Argilés Martinez, Guillem; Martini, Giulia; Ciardiello, Davide; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2021-01) -
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
García-Alfonso, Pilar; Muñoz, Andrés; Jiménez-Castro, Jerónimo; Jimenez-Fonseca, Paula; Pericay, Carles; Longo-Muñoz, Federico; Argilés Martinez, Guillem (MDPI, 2021-09-08) -
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis
Tabernero Caturla, Josep; Argilés Martinez, Guillem; Sobrero, Alberto; Borg, Christophe; Ohtsu, Atsushi; Mayer, Robert (BMJ, 2020-08-19) -
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
Lenz, Heinz-Josef; Argilés Martinez, Guillem; Yoshino, Takayuki; Lonardi, Sara; Falcone, Alfredo; Limón, María Luisa (Elsevier, 2019-12) -
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
Elez Fernandez, Mª Elena; Chianese, Chiara; Matito Ariza, Judit; Macarulla Mercadé, Teresa; Argilés Martinez, Guillem; Capdevila Castillon, Jaume; Garcia Rodriguez, Ariadna; Mulet Margalef, Núria; Tabernero Caturla, Josep; Vivancos Prellezo, Ana; Sanz Garcia, Enrique; Martinelli, Erica; Noguerido Castro, Alba; Mancuso, Francesco Mattia; Caratù, Ginevra; Grasselli, Julieta; Martini, Giulia (FEBS Press, 2019-07-31) -
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
Martini, Giulia; Dienstmann, Rodrigo; Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Cuadra-Urteaga, Jose Luis; Salva Ballabrera, Francesc; Ciardiello, Davide; Mulet Margalef, Núria; Argilés Martinez, Guillem; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2020-07-24) -
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Yoshino, T.; Cleary, J. M.; Van Cutsem, E.; Mayer, Robert; Ohtsu, Atsushi; Shinozaki, E.; Argilés Martinez, Guillem (Elsevier, 2020-01) -
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study
Bordonaro, R.; Calvo, A.; Auriemma, A.; Hollebecque, Antoine; Rubovszky, G.; Saunders, M. P.; Argilés Martinez, Guillem; Tabernero Caturla, Josep (Elsevier, 2021-10) -
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study
Van Cutsem, E.; Danielewicz, I.; Saunders, M. P.; Pfeiffer, P.; Argilés Martinez, Guillem; Borg, Christophe (Elsevier, 2020-09)